Butadiene: Species comparison for metabolism and genetic toxicology

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 405, Issue 2, 1998, Pages 247-258

  Anderson, Diana ^a  

^a BIBRA INTERNATIONAL   (United Kingdom)

Author keywords

Butadiene; Genetic toxicology assay; Metabolism

Indexed keywords

1,3 BUTADIENE; DRUG METABOLITE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DRUG DEGRADATION; GENETIC TOXICOLOGY; GENOTOXICITY; MONKEY; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; TOXICOKINETICS; XENOBIOTIC METABOLISM;

ANIMALS; BUTADIENES; HUMANS; MICE; MUTAGENS; RATS; SPECIES SPECIFICITY;

EID: 0032552641     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00142-0     Document Type: Conference Paper

References (94)

1. [1] J.M. Fajen, R.A. Lunsford, D.R. Roberts, Occupational exposure of workers to 1,3-butadiene, in: M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene. Assessment of Health Hazards IARC, Scientific Publications No. 27, International Agency for Research on Cancer, Lyon, 1993, pp. 3-13.
2. [2] R.L. Melnick, J. Huff, B.J. Chou, R.A. Miller, Carcinogenicity of 1,3-butadiene in (C57B1/6×C3H)F1 mice at low exposure concentrations, Cancer Res. 50 (1990) 6592-6599.
3. [3] M.W. Himmelstein, J.F. Acquavella, L. Recio, M.A. Medinski, J.A. Bond, Toxicology and epidemiology of 1,3-butadiene, Crit. Rev. Toxicol. 27 (1997) 1-108.
4. [4] International Agency for Research on Cancer, 1,3-Butadiene, in: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 54, Occupational Exposures to Mists and Vapours from Strong Inorganic Acids, and Other Industrial Chemicals, World Health Organization, Lyon, France, 1992, pp. 237-285.
5. [5] R.F. Henderson, J.R. Thornton-Manning, W.E. Bechtold, A.R. Dahl, Metabolism of 1,3-butadiene: species differences, Toxicology 113 (1996) 17-22.
6. [6] H. Raunio, K. Husgafvel-Pursiainen, S. Anttila, E. Hietanen, A. Hironen, O. Pelkonen, Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review, Gene 159 (1995) 113-121.
7. [7] E. Delzell, N. Sathiakumar, M. Hovinga, M. Macaluso, J. Julian, R. Larson, P. Cole, D.C.F. Muir, A follow-up study of synthetic rubber workers, Toxicology 113 (1996) 182-189.
8. [8] M. Macaluso, R. Larson, E. Delsell, N. Sathiakumar, M. Hovinga, J. Julian, D. Muir, P. Cole, Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry, Toxicology 113 (1996) 190-202.
9. [9] E.M. Ward, J.M. Fajen, A.M. Ruder, R.A. Rinsky, W.E. Halperin, C.A. Fessler-Flesch, Mortality study of workers employed in 1,3-butadiene production units identified from a large chemical workers cohort, Toxicology 113 (1996) 157-168.
10. [10] B.J. Divine, C.M. Hartman, Mortality update of butadiene production workers, Toxicology 113 (1996) 169-181.
11. [11] ECETOC, Special Report No. 12, 1,3-Butadiene OEL Criteria Document, 2nd edn., Cas. No. 106-99-0, 1997, 1-57.
12. [12] E. Malvoisin, G. Lhoest, F. Poncelet, M. Roberfroid, M. Mercier, Identification and quantisation of 1,2-epoxybutene-3 as the primary metabolite of 1,3-butadiene, J. Chromatogr. 178 (1979) 419-425.
13. [13] H.M. Bolt, G. Schmeidel, J.G. Filser, H.P. Rolzhauser, K. Lieser, D. Wistuba, V. Schurig, Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats, J. Cancer Res. Clin. Oncol. 106 (1983) 112-116.
14. [14] D. Wistuba, H.P. Nowotny, O. Trágerf, V. Sahurig, Cytochrome P-450 catalysed asymmetric epoxidation of simple prochiral and chiral aliphatic alkenes: species dependence and effect on enzyme induction on enantioselective oxirane formation, Chirality 1 (1989) 127-136.
15. [15] A.A. Elfarra, R.J. Duescher, C.M. Pasch, Mechanisms of 1,3-butadiene oxidations to butadiene monoxide and crotonaldehyde by mouse liver microsomes and chloroperoxidase, Arch. Biochem. Biophys. 286 (1991) 244-251.
16. [16] J.E. Sharer, R.J. Duescher, A.A. Elfarra, Species and tissue differences in the microsomal oxidation of 1,3-butadiene and the gluthathione conjugation of butadiene monoxide in mice and rats: possible role in 1,3-butadiene-induced toxicity, Drug Metab. Dispos. 20 (1992) 658-664.
17. [17] R.J. Duescher, A.A. Elfarra, Human liver microsomes are efficient catalysts for 1,3-butadiene oxidation: evidence for major roles by cytochrome P4502A6 and 2E1, Arch. Biochem. Biophys. 311 (1994) 342-349.
18. [18] G.A. Csanády, F.P. Guengerich, J.A. Bond, Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice, Carcinogenesis 13 (1992) 1143-1153.
19. [19] M.J. Seaton, M.H. Follansbee, J.A. Bond, Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochrome P4502E1 and 3A4 and human, mouse and rat liver microsomes, Carcinogenesis 16 (1995) 2287-2293.
20. [20] J.E. Scharer, R.J. Duescher, A.A. Elfarra, Formation, stability and rearrangements of the glutathione conjugates of butadiene monoxide: evidence for the formation of stable sulfurane intermediates, Chem. Res. Toxicol. 4 (1991) 430-436.
21. [21] E. Malvoisin, M. Roberfroid, Hepatic microsomal metabolism of 1,3-butadiene, Xenobiotica 12 (1982) 137-144.
22. [22] P.E. Kreuzer, W. Kessler, H.F. Welter, C. Baur, J.G. Filser, Enzyme specific kinetics of 1,2-epoxybutene-3 in microsomes and cytosol from livers of mouse, rat and man, Arch. Toxicol. 65 (1991) 59-67.
23. [23] X. Cheng, R.A. Ruth, A simplified methodology for quantisation of butadiene metabolites: application to the study of 1,3-butadiene metabolism by rat liver microsomes, Drug Metab. Dispos. 21 (1993) 121-124.
24. 13C]butadiene, Chem. Res. Toxicol. 9 (1996) 764-773.
25. [25] P.J. Boogaard, S.C.J. Sumner, J.A. Bond, Glutathione conjugation of 1,2:3,4-diepoxybutane in human liver and rat and mouse liver and lung in vitro, Toxicol. Appl. Pharmacol. 136 (1996) 307-316.
26. [26] P.J. Boogaard, J.A. Bond, The role of hydrolysis in the detoxication of 1,2:3,4-diepoxybutane by human, rat and mouse liver and lung in vitro, Toxicol. Appl. Pharmacol. 141 (1996) 617-627.
27. [27] U. Schmidt, E. Loeser, Species differences in the formation of butadiene monoepoxide from 1,3-butadiene, Arch. Toxicol. 57 (1985) 222-225.
28. [28] C. Maniglier-Paulet, X. Cheng, J.A. Ruth, D. Ross, Metabolism of 1,3-butadiene to butadiene monoxide in mouse and human bone marrow cells, Chem. Biol. Int. 97 (1995) 119-129.
29. [29] C.O. Davis, M. Pirmohamed, N.R. Kitteringham, R.L. Allott, D. Smith, B.K. Park, Kinetic parameters of lymphocyte microsomal epoxide hydrolyase in carbamazipine hypersensitive patients: assessment by radiometric HPLC, Biochem. Pharmacol. 50 (1995) 1361-1366.
30. [30] C. Hassett, L. Aicher, J.S. Sidhu, C.J. Omiecinski, Human microsomal epoxide hydrolyse: genetic polymorphism and functional expression in vitro of amino acid variants, Human Mol. Genet. 3 (1994) 421-428.
31. [31] J.A. Bond, A.R. Dahl, R.F. Henderson, J.S. Dutcher, J.L. Mauderly, L.S. Birnbaum, Species differences in the disposition of inhaled butadiene, Toxicol. Appl. Pharmacol. 84 (1986) 617-627.
32. [32] A.R. Dahl, J.D. Sun, L.S. Birnbaum, J.A. Bond, W.C. Griffith Jr., J.L. Mauderly, B.A. Muggenburg, P.J. Saboruin, R.F. Henderson, Toxicokinetics of inhaled 1,3-butadiene in monkeys: comparison to toxicokinetics in rats and mice, Toxicol. Appl. Pharmacol. 110 (1991) 9-19.
33. [33] W.E. Bechtold, M.R. Strunk, J.R. Thornton-Manning, R.F. Henderson, Analysis of butadiene, butadiene monoxide, and butadiene dioxide in blood by gas chromatography/gas chromatograph/mass spectroscopy, Chem. Res. Toxicol. 8 (1995) 182-187.
34. [34] J.R. Thornton-Manning, A.R. Dahl, W.E. Bechtold, W.C. Griffith Jr., R.F. Henderson, Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene, Carcinogenesis 16 (1995) 1723-1731.
35. [35] J.R. Thornton-Manning, A.R. Dahl, W.E. Bechtold, W.C. Griffith Jr., L. Pei, R.F. Henderson, Gender differences in the metabolism of 1,3-butadiene in Sprague-Dawley rats following a low-level inhalation exposure, Carcinogenesis 16 (1995) 2875-2878.
36. [36] R. Kreiling, R.J. Laib, J.G. Filser, H.M. Bolt, Inhalation pharmacokinetics of 1,2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene induced carcinogenesis, Arch. Toxicol. 61 (1987) 7-11.
37. [37] R. Kreiling, R.J. Laib, H.M. Bolt, Depletion of hepatic non-protein sulfhydryl content during exposure of rats and mice to butadiene, Toxicol. Lett. 41 (1988) 209-214.
38. [38] J.G. Filser, H.M. Bolt, Inhalation pharmacokinetics based on gas uptake studies: VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats, Arch. Toxicol. 55 (1994) 219-223.
39. [39] J.A. Bond, A.R. Dahl, R.F. Henderson, L.S. Birnbaum, Species differences in the distribution of inhaled butadiene in tissues, Am. Ind. Hyg. Assoc. J. 48 (1987) 867-872.
40. [40] M.W. Himmelstein, M.J. Turner, B. Asgharian, J.A. Bond, Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation, Carcinogenesis 15 (1994) 1479-1486.
41. [41] M.W. Himmelstein, B. Asgharian, J.A. Bond, High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene, Toxicol. Appl. Toxicol. 132 (1995) 281-288.
42. [42] P.J. Sabourin, L.T. Burka, W.E. Bechtold, A.R. Dahl, M.D. Hoover, L.-Y. Chang, R.F. Henderson, Species differences in urinary butadiene metabolites, identification of 1,2-dihydroxy-4-(N-acetylcysteinyl)butane, a novel metabolite of butadiene, Carcinogenesis 13 (1992) 1633-1638.
43. [43] F.H. Sobels, Approaches to assessing genetic risks from exposure to chemicals, Environ. Health Perspect. 101 (1993) 327-332, Suppl. 3.
44. [44] F.H. Sobels, Evaluating the mutagenic potential of chemicals. The minimal battery and extrapolation problems, Arch. Toxicol. 46 (1980) 21-30.
45. [45] F.H. Sobels, Models and assumptions underlying genetic risk assessment, Mutat. Res. 212 (1989) 77-89.
46. 6-adenine adducts of epoxybutene detected by P-postlabelling and HPLC, Environ. Health Perspect. 104 (1996) 655-657, Suppl. 3.
47. 32P-post-labelling/HPLC assay reveals an enantiospecific adduct formation in N7 guanine residues in vivo after 1,3-butadiene inhalation exposure, Carcinogenesis 18 (1997) 439-443.
48. [48] P. Koivisto, I.-D. Adler, F. Pacchierotti, K. Peltonen, DNA adducts on mouse testis and lung after inhalation exposure to 1,3-butadiene, Mutat. Res. 397 (1998) 3-10.
49. [49] S. Osterman-Golkar, K. Peltonen, T. Anttinen-Klemetti, H.H. Landin, V. Zorcec, M. Sorsa, Haemoglobin adducts as biomarkers of occupational exposure to 1,3-butadiene, Mutagenesis 11 (1996) 145-149.
50. [50] S. Osterman-Golkar, J.A. Bond, J.B. Ward, Jr., M.S. Legator, The use of haemoglobin adducts as a tool for biomonitoring butadiene exposure, in: M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene: Assessment of Health Hazards, IARC Scientific Publications No. 127, 1993, pp. 127-134.
51. [51] H. Licea Pérez, H. Lähdetie, H. Hindso Landin, I. Kilpeläinen, P. Koivisto, K. Peltonen, S. Osterman-Golkar, Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides, Chem. Biol. Interact. 105 (1997) 181-198.
52. [52] F. Pacchierotti, I.-D. Adler, D. Anderson, M. Brinkworth, N.A. Demopoulos, J. Lahdetie, S. Osterman-Golkar, K. Peltonen, A. Russo, A. Tates, R. Waters, Genetic effects of 1,3-butadiene and associated risk for heritable damage, Mutat. Res., 1997, in press.
53. [53] J.E. Cochrane, T.R. Skopek, Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epxoybutene, 1,2,34-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts, Carcinogenesis 15 (1994) 713-717.
54. [54] S. Bernardini, K. Pelin, K. Peltonen, H. Järventaus, A. Hirvonen, C. Neagu, M. Sorsa, H. Norppa, Induction of sister chromatid exchange by 3,4-epoxybutane-1,2-diol in cultured human lymphocytes of different GSTT1 and GSTM1 genotypes, Mutat. Res. 361 (1996) 121-127.
55. [55] I.-D. Adler, L. Nyland, U. Kliesch, K. Peltonen, In vitro and in vivo mutagenicity of the butadiene metabolites butadiene diolepoxide, butadiene monoepoxide and diepoxybutane, Mutagenesis 12 (1997) 239-245.
56. [56] U.H. Ehling, Induction of gene mutations in germ cells of the mouse, Arch. Toxicol. 46 (1980) 123-128.
57. [57] U.H. Ehling, Risk estimation based on germ cell mutations in mice, in: T. Sugimura, S. Kondo, H. Takebe (Eds.), Environmental Mutagens and Carcinogens. University of Tokyo Press, Tokyo, Alan R. Liss, New York, pp. 709-719.
58. [58] G. Stephanou, A. Russo, D. Vlastos, C. Andrianopoulos, N.A. Demopoulos, Micronucleus induction in somatic cells of mice as evaluated after 1,3-butadiene inhalation, Mutat. Res. 397 (1998) 11-20.
59. [59] Y. Xiao, A.D. Tates, Clastogenic effects of 1,3-butadiene and its metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane in splenocytes and germ cells of rats and mice in vivo, Environ. Mol. Mutagen. 26 (1995) 97-108.
60. [60] G. Stephanou, C. Andrianopoulos, D. Vlastos, N.A. Demopoulos, A. Russo, Induction of micronuclei and sister chromatid exchanges in mouse splenocytes after exposure to the butadiene metabolite 3,4-epoxy-1-butene, Mutagenesis 12 (1997) 425-429.
61. [61] K. Autio, L. Renzi, J. Catalan, O.E. Albrecht, M. Sorsa, Induction of micronuclei in peripheral blood and marrow erthyrocytes of rats and mice exposed to 1,3-butadiene by inhalation, Mutat. Res. 309 (1994) 315-320.
62. [62] J. Lähdetie, J. Grawé, Flow cytometric analysis of micronucleus induction in rat bone marrow polychromatic erythrocytes by 1,2:3,4-diepoxybutane, 3,4-epoxy-1-butene and 1,2-epoxybutane-3,4-diol, Cytometry 28 (1997) 228-235.
63. [63] D. Anderson, M.M. Dobrzynska, L.L. Jackson, T.W. Yu, M.H. Brinkworth, Somatic and germ cell effects in rats and mice after treatment with 1,3-butadiene and its metabolites, 1,2-epoxybutene and 1,2,3,4-diepoxybutane, Mutat. Res. 391 (1997) 233-242.
64. [64] M. Sorsa, K. Autio, N.A. Demopoulos, H. Järventaus, P. Rössner, R.J. Sram, G. Stephanou, D. Vlachodimitropoulos, Human cytogenetic biomonitoring of occupational exposure to 1,3-butadiene, Mutat. Res. 309 (1994) 312-326.
65. [65] D. Anderson, J.A. Hughes, K. Peltonen, M. Sorsa, Levels of ras oncoproteins in human plasma 1,3-butadiene exposed workers and controls, Mutat. Res., 1996, 115-120.
66. [66] A.D. Tates, F.J. van Dam, F.A. de Zwart, F. Darroudi, A.T. Nalarajan, P. Rössner, K. Peterkova, K. Peltonen, N.A. Demopoulos, G. Stephanou, D. Vlachodimitropoulos, R.J. Sram, Biological effect monitoring in industrial workers from the Czech Republic exposed to low levels of butadiene, Toxicology 113 (1996) 91-99.
67. [67] R. Sram, P. Rössner, K. Peterkova, G. Mrackova, K. Peltonen, N.A. Demopoulos, D. Vlachidimitropoulos, G. Stephanou, Cytogenetic biomonitoring of workers exposed to 1,3-butadiene. 26th EEMS Annual Meeting: Workshop on Chromosome Instability and Cell Cycle Control, Abstract Book, Instituto Superiore di Sanita, Rome, 3.-7.9, 1996, p. 244.
68. 1 mice and F344 rats, Environ. Mol. Mutagen. 27 (1996) 48, Suppl. 27.
69. [69] A.D. Tates, F.J. van Dam, C.M.M. van Teylingen, F.A. de Zwart, A.H. Zwinderman, Comparison of induction of HPRT mutations by 1,3-butadiene and its metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane in lymphocytes from spleen of adult male mice and rats in vivo, Mutat. Res., 1997, in press.
70. [70] M.S. Legator, W.W. Au, M.M. Ammenhauser, J.B. Ward, Jr., Elevated somatic cell mutant frequencies and altered DNA repair responses in nonsmoking workers exposed to 1,3-butadiene, in: M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene: Assessment of Health Hazards, IARC Scientific Publications No. 127, 1993, pp. 253-263.
71. [71] A.M. Tommasi, S. de Conti, M.M. Dobrzynska, A. Russo, Evaluation and characterization of micronuclei in early spermatids of mice exposed to 1,3-butadiene, Mutat. Res. 8 (1998) 45-54.
72. [72] A. Russo, C. Nogara, L. Renzi, A.M. Tommasi, Micronucleus induction in germ and somatic cells of the mouse after exposure to the butadiene metabolites diepoxybutane and epoxybutene, Mutat. Res. 390 (1997) 129-139.
73. [73] W.W. Au, W.E. Bechtold, E.B. Whorton Jr, M.S. Legator, Chromosome aberrations and response to γ-ray challenge in lymphocytes or workers exposed to 1,3-butadiene, Mutat. Res. 334 (1995) 125-130.
74. [74] J.B. Ward, M.M. Ammenheuser, E.B. Whorton Jr, W.E. Bechtold, K.T. Kelsey, M.S. Legator, Biological monitoring for mutagenic effects of occupational exposure to butadiene, Toxicology 113 (1996) 157-168.
75. [75] R.B. Hayes, L. Xi, W.E. Bechtold, N. Rothman, M. Yao, R. Henderson, L. Zhang, M.T. Smith, D. Zhang, J. Wiemels, M. Dosemeci, S. Yin, J.P. O' Neill, hprt mutation frequency among workers exposed to 1,3-butadiene in China, Toxicology 113 (1996) 100-105.
76. [76] M. Sorsa, S. Osterman-Golkar, K. Peltonen, S.T. Saarikoski, R. Sram, Assessment of exposure to butadiene in the process industry, Toxicology 113 (1996) 77-83.
77. [77] J. Lähdetie, K. Peltonen, T. Sjöblom, Germ cell mutagenicity of three metabolites of 1,3-butadiene in the rat: induction of spermatid micronuclei by butadiene mono-, di-, and diolepoxides in vivo, Environ. Mol. Mutagen. 29 (1997) 230-239.
78. [78] I.-D. Adler, J. Cao, J.G. Filser, P. Gassner, W. Kessler, U. Kliesch, A. Neuhäuser-Klaus, M. Nüsse, Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice, Mutat. Res. 309 (1994) 307-314.
79. [79] M.H. Brinkworth, D. Anderson, J.A. Hughes, L.I. Jackson, T.W. Yu, E. Nieschlag, Genetic effects of 1,3-butadiene on the mouse testis, Mutat. Res. 397 (1998) 67-75.
80. 1 effects in mice exposed to 1,3-butadiene, in: M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene: Assessment of Health Hazards, IARC Scientific Publications No. 127, pp. 171-181.
81. [81] I.-D. Adler, J. Filser, H. Gonda, G. Schriever-Schwemmer, Dose response study for 1,3-butadiene-induced dominant lethal mutations and heritable translocations in germ cells of male mice, Mutat. Res. 397 (1998) 85-92.
82. [82] D. Anderson, J.A. Hughes, A.J. Edwards, M.H. Brinkworth, A comparison of male-mediated effects in rats and mice exposed to 1,3-butadiene, Mutat. Res. 397 (1998) 77-84.
83. [83] I.-D. Adler, U. Kliesch, C. Tiveron, F. Pacchierotti, Clastogenicity of diepoxybutane in bone marrow cells and male germ cells of mice, Mutagenesis 10 (1995) 535-541.
84. [84] I.-D. Adler, Comparison of the duration of spermatogenesis between male rodents and humans, Mutat. Res. 352 (1996) 169-172.
85. [85] I.-D. Adler, J.G. Filser, P. Gassner, W. Kessler, J. Schöneich, G. Schriever-Schwemmer, Heritable translocations induced by inhalation exposure of male mice to 1,3-butadiene, Mutat. Res. 347 (1995) 121-127.
86. [86] ACGIH, Threshold Limit Values for Chemical Substances and Physical Agents. American Conference of Governmental Industrial Hygienists, Technical Information Office, Cincinnati, OH, USA, 1996, p. 15.
87. [87] HSE (UK Health and Safety Executive), Occupational exposure limits 1995, HMSO, London, UK, 1995, p. 27.
88. [88] Arbeidsinspectie, De nationale MAC-list 1995. Directoraat van de Arbeid, Ministerie van Sociale Zanken en Werkgelegenheid, Voorburg, The Netherlands, 1995, p. 23.
89. [89] J.A. Bond, G.A. Csanády, T. Leavens, M.A. Medinsky, Research strategy for assessing target issue dosimetry of 1,3-butadiene in laboratory animals and humans, in: M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene: Assessment of Health Hazards, IARC Scientific Publications No. 127, International Agency for Research on Cancer, Lyon, 1993, pp. 45-55.
90. [90] J.A. Bond, L. Recio, D. Andjelkovich, Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace, Carcinogenesis 13 (1995) 1143-1153.
91. [91] J.A. Bond, L. Recio, M. Medinsky, Letter to the Editor, J. Clean Technol. Environ. Toxicol. and Occup. Med. 6, 1997, in press.
92. [92] M.S. Legator, Letter to the Editor, J. Clean Technol. Environ. Toxicol. Occup. Med. 6 (1997) 1052-1062.
93. 1 mice, Toxicology 113 (1996) 253-262.
94. [94] D. Anderson, M. Sorsa, M.D. Waters, The parallelogram approach in studies of genotoxic effects, Mutat. Res. 313 (1994) 101-115.